Susquehanna Portfolio Strategies »

Keros Therapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $480k 45k 10.70

More positions owned by Susquehanna Portfolio Strategies

Intel Corporation (INTC)
Abbvie (ABBV)
Sherwin-Williams Company (SHW)
Medtronic SHS (MDT)
Philip Morris International (PM)
Starbucks Corporation (SBUX)
Costco Wholesale Corporation (COST)
Humana (HUM)
Prologis (PLD)
Williams Companies (WMB)
Devon Energy Corporation (DVN)
Equinix (EQIX)
Metropcs Communications (TMUS)
Monster Beverage Corp (MNST)
Cigna Corp (CI)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Keros Therapeutics

BlackRock
Nantahala Capital Management
AQR Capital Management
Vanguard Capital Management
OrbiMed Advisors
Federated Investors
Vanguard Portfolio Management
Mackenzie Financial
Madison Avenue Partners
Qube Research & Technologies
Jacobs Levy Equity Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors

View all funds holding Keros Therapeutics